Concert Pharmaceuticals, Inc. Assets, Fair Value Disclosure
Concert Pharmaceuticals, Inc. had Assets, Fair Value Disclosure of $101.55 million as of 2019-12-31, per its 10-K filed 2020-02-27.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures
us-gaap:AssetsFairValueDisclosure · last filed 2020-02-27
- 2019-12-31: Assets, Fair Value Disclosure $101.55M.
- 2018-12-31: Assets, Fair Value Disclosure $152.46M.
- 2015-09-30: Assets, Fair Value Disclosure $140.59M.
- 2015-06-30: Assets, Fair Value Disclosure $150.26M.
| Period end | Assets, Fair Value Disclosure |
|---|---|
| 2019-12-31 | $101.55M 10-K · filed 2020-02-27 |
| 2018-12-31 | $152.46M 10-K · filed 2020-02-27 |
| 2015-09-30 | $140.59M 10-Q · filed 2015-11-05 |
| 2015-06-30 | $150.26M 10-Q · filed 2015-08-05 |
| 2015-03-31 | $111.53M 10-Q · filed 2015-05-11 |
| 2014-12-31 | $77.74M 10-Q · filed 2015-11-05 |
| 2014-09-30 | $86.78M 10-Q · filed 2014-11-12 |
| 2014-06-30 | $97.13M 10-Q · filed 2014-08-12 |
| 2014-03-31 | $107.01M 10-Q · filed 2014-05-14 |
| 2013-12-31 | $30.49M 10-K · filed 2015-03-02 |